Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Insys Therapeutics Inc Announces Pricing of Initial Public Offering


Thursday, 2 May 2013 09:12am EDT 

Insys Therapeutics Inc announced the pricing of its initial public offering of four million shares of its common stock at a price to the public of $8.00 per share. The shares of Insys' common stock will trade on the NASDAQ Global Market under the symbol INSY. All of the shares of common stock are being offered by Insys. In addition, the company has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock at the initial public offering price to cover over-allotments, if any. Wells Fargo Securities, LLC and JMP Securities LLC are acting as joint book-running managers for the offering. Oppenheimer & Co. is acting as co-manager. 

Latest Developments for Insys Therapeutics Inc

Company Quote

36.76
0.01 +0.03%
4:00pm EDT